HPV and prognosis for patients with oropharynx cancer

European Journal of Cancer

Volumn 45, Issue SUPPL. 1, 2009, Pages 383-385

  Gillison, Maura L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PACLITAXEL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISEASE CLASSIFICATION; HAZARD RATIO; HEAD AND NECK CANCER; HEALTH STATUS; HUMAN; IN SITU HYBRIDIZATION; METASTASIS; MULTIMODALITY CANCER THERAPY; NONHUMAN; OBSERVATIONAL STUDY; OROPHARYNX CANCER; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIZATION; RECURRENT CANCER; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; SMOKING; SQUAMOUS CELL CARCINOMA; WART VIRUS;

CLINICAL TRIALS AS TOPIC; HUMANS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 70349134272     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(09)70058-9     Document Type: Article

References (16)

1. Mellin H., Friesland S., Lewensohn R., Dalianis T., and Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89 (2000) 300-304
2. Gillison M.L., Koch W.M., Capone R.B., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 (2000) 709-720
3. Schwartz S.R., Yueh B., McDougall J.K., Daling J.R., and Schwartz S.M. Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study. Otolaryngol Head Neck Surg 125 (2001) 1-9
4. Lindel K., Beer K.T., Laissue J., Greiner R.H., and Aebersold D.M. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer 92 (2001) 805-813
5. Ragin C.C., and Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer 121 (2007) 1813-1820
6. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 (2008) 261-269
7. Gillison M., Harris J., Westra W., et al. Survival outcomes by tumor human papillomaviurs status in stage III-IV oropharyngeal cancer in RTOG 0129. J Clin Oncol (2009) Abstract 6003.
8. Licitra L., Perrone F., Bossi P., et al. High-risk Human Papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24 (2006) 5630-5636
9. Lindquist D., Romanitan M., Hammarstedt L., et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol 1 (2007) 350-355
10. Chaturvedi A.K., Engels E.A., Anderson W.F., and Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26 (2008) 612-619
11. Kumar B., Cordell K., Lee J., et al. EGFR, p16, HPVtiter, Bcl-xl, and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 26 (2008) 3128-3137
12. Hafkamp H., Manni J., Haesevoets A., et al. Marked differences in survival rate between smokers and nonsmokers with HPV16-assocaited tonsillar carcinomas. Int J Cancer 122 (2008) 2656-2664
13. Agrawal Y., Koch W., Xiao W., et al. Oral HPV Infection before and after treatment for HPV16-positive and negative head and neck squamous cell carcinoma. Clin Cancer Res 14 (2008) 7143-7150
14. Reimers N., Kapar H., Weissenborn S., et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer 120 (2007) 1731-1738
15. Westra W., Taube J., Poeta M., Begum S., Sidransky D., and Koch W. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res 14 (2008) 366-369
16. Preuss S., Weinell A., Molitor M., et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. Br J Cancer 98 (2008) 627-632